Deferasirox (Exjade (R), ICL670) demonstrates dose-related effects on body iron levels related to transfusional iron intake in transfusion-dependent anemia Greenberg, P., Dine, G., Ganser, A., Verhoef, G., DeBusscher, L., Quarta, G., Zachee, P., Alimena, G., Jeng, M., Tchernia, G., Gathmann, Alberti, D., Rabault, B. AMER SOC HEMATOLOGY. 2005: 757A

View details for Web of Science ID 000233426005014